General Range

TRANEXA FEMI

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

TRANEXA FEMI Injection by Fortune Labs contains Tranexamic Acid, a prescription antifibrinolytic medicine used for managing selected conditions involving excessive bleeding. Tranexamic Acid works by inhibiting the breakdown of fibrin blood clots, helping reduce blood loss when excessive fibrinolysis contributes to bleeding. TRANEXA FEMI may be administered for selected surgical bleeding, postpartum haemorrhage and other approved bleeding-related conditions when clinically appropriate. Available in protective carton packaging containing five 5 ml ampoules, the formulation is intended for intravenous administration by trained healthcare professionals according to approved instructions. Treatment requires careful consideration of kidney function, thromboembolic risk, seizure history, potential medication interactions and appropriate administration rates. Incorrect administration routes can cause life-threatening complications.

CategoryGeneral Range

Min. Order100 boxes

Supplied byFortune Labs

CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition: Tranexamic Acid Injection IP
Packaging Type: Glass Injection Ampoules in Protective Plastic Tray with Printed Carton Box
Packaging Size: 5 Ampoules of 5 ml Each
Dosage Form: Injectable Solution
Treatment: May be administered as part of emergency treatment for clinically diagnosed postpartum haemorrhage.
Shelf Life: 24 Months
Storage: Store below 30°C, protect from light & moisture
Certification: WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana

View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?